Biogen Idec (BIIB) up on reports of an effective drug-cleansing treatment for TYSABRI patients with PML
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) higher ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
